Hansoh Pharmaceutical Group Company Limited

Informe acción SEHK:3692

Capitalización de mercado: HK$107.2b

Dividendos de Hansoh Pharmaceutical Group

Dividendo controles de criterios 0/6

Hansoh Pharmaceutical Group es una empresa que paga dividendos con una rentabilidad actual de 1.69%. La fecha del próximo pago es en 17th July, 2024 con una fecha ex dividendo de 19th June, 2024.

Información clave

1.6%

Rentabilidad por dividendo

35%

Ratio de pago

Rentabilidad media de la industria3.3%
Próxima fecha de pago de dividendos17 Jul 24
Fecha ex dividendo19 Jun 24
Dividendo por acciónn/a
Beneficios por acciónHK$0.55
Rentabilidad por dividendo prevista a 3 años1.0%

Últimas actualizaciones de dividendos

Hansoh Pharmaceutical Group's (HKG:3692) Upcoming Dividend Will Be Larger Than Last Year's

Sep 14
Hansoh Pharmaceutical Group's (HKG:3692) Upcoming Dividend Will Be Larger Than Last Year's

Recent updates

Hansoh Pharmaceutical Group Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

May 01
Hansoh Pharmaceutical Group Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Do Hansoh Pharmaceutical Group's (HKG:3692) Earnings Warrant Your Attention?

Mar 28
Do Hansoh Pharmaceutical Group's (HKG:3692) Earnings Warrant Your Attention?

There's Reason For Concern Over Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Massive 28% Price Jump

Mar 04
There's Reason For Concern Over Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Massive 28% Price Jump

An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 28% Undervalued

Feb 16
An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 28% Undervalued

Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Quite Sensibly

Dec 08
Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Quite Sensibly

Hansoh Pharmaceutical Group Company Limited (HKG:3692) Shares Could Be 25% Below Their Intrinsic Value Estimate

Oct 12
Hansoh Pharmaceutical Group Company Limited (HKG:3692) Shares Could Be 25% Below Their Intrinsic Value Estimate

Hansoh Pharmaceutical Group's (HKG:3692) Upcoming Dividend Will Be Larger Than Last Year's

Sep 14
Hansoh Pharmaceutical Group's (HKG:3692) Upcoming Dividend Will Be Larger Than Last Year's

These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well

Sep 09
These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well

Calculating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

Jul 10
Calculating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well

Jun 11
These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well

Calculating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

Jan 23
Calculating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet

Dec 01
Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet

Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 65% Above Its Share Price

Oct 19
Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 65% Above Its Share Price

Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt

Aug 28
Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt

An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 44% Undervalued

Jun 09
An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 44% Undervalued

Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Popularity With Investors Is Under Threat From Overpricing

May 19
Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Popularity With Investors Is Under Threat From Overpricing

Is Hansoh Pharmaceutical Group (HKG:3692) A Risky Investment?

Apr 22
Is Hansoh Pharmaceutical Group (HKG:3692) A Risky Investment?

An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 45% Undervalued

Feb 06
An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 45% Undervalued

Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 43% Above Its Share Price

Nov 07
Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 43% Above Its Share Price

Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet

Oct 11
Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet

A Look At The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

Jul 14
A Look At The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

The Hansoh Pharmaceutical Group (HKG:3692) Share Price Is Up 51% And Shareholders Are Holding On

Jan 31
The Hansoh Pharmaceutical Group (HKG:3692) Share Price Is Up 51% And Shareholders Are Holding On

Will Weakness in Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Stock Prove Temporary Given Strong Fundamentals?

Dec 08
Will Weakness in Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Stock Prove Temporary Given Strong Fundamentals?

Próximo pago de dividendos

HoyMay 11 2024Fecha ex dividendoJun 19 2024Fecha de pago de dividendosJul 17 202428 days desde ex dividendoCompra en los próximos 39 days para recibir el próximo dividendo

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: 3692 no paga un dividendo notable para el mercado Hong Kong, por lo que no es necesario comprobar si los pagos son estables.

Dividendo creciente: 3692 no paga un dividendo notable para el mercado Hong Kong, por lo que no es necesario comprobar si los pagos aumentan.


Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de Hansoh Pharmaceutical Group vs. Mercado
¿Cómo se compara la rentabilidad por dividendo de 3692 con la del mercado?
SegmentoRentabilidad por dividendo
Empresa (3692)1.6%
Suelo de mercado 25% (HK)3.1%
Techo de mercado 25% (HK)7.6%
Media de la industria (Pharmaceuticals)3.3%
Previsión de analistas en 3 años (3692)1.0%

Dividendo destacado: El dividendo de 3692(1.69%) no es notable en comparación con el 25% inferior de pagadores de dividendos del mercado Hong Kong (3.39%).

Alto dividendo: El (1.69%) del dividendo de 3692 es bajo en comparación con el 25% de los principales pagadores de dividendos del mercado Hong Kong (8.24%).


Pago de beneficios a los accionistas

Cobertura de los beneficios: 3692 no paga un dividendo notable para el mercado Hong Kong.


Pago en efectivo a los accionistas

Cobertura de flujo de caja: 3692 no paga un dividendo notable para el mercado Hong Kong.


Discover strong dividend paying companies